Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Domchek

Showing results (271-280 of 361) with videos related to

Pageof 37
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2024
Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the BreastHuaizhi Huang, Ronan E Couch, Rachid Karam, et al.
JAMA Oncology|October 9, 2025
Pathogenic Variants, Family History, and Cumulative Risk of Breast Cancer in US WomenKatie M O'Brien, Alexander P Keil, Jack A Taylor, et al.
Cancer Research|May 30, 2023
Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51CChunling Hu, Anil Belur Nagaraj, Hermela Shimelis, et al.
Plos Genetics|December 27, 2018
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2Melissa S Cline, Rachel G Liao, Michael T Parsons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2024
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g<i>BRCA1/2</i> Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast CancerPatricia A Ganz, Hanna Bandos, Tanja Španić, et al.
Human Molecular Genetics|April 27, 2010
Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriersXianshu Wang, V Shane Pankratz, Zachary Fredericksen, et al.
The New England Journal of Medicine|August 8, 2014
Breast-cancer risk in families with mutations in PALB2Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, et al.
Human Mutation|May 22, 2019
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestryTara M Friebel, Irene L Andrulis, Judith Balmaña, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2021
Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk ScoreChi Gao, Eric C Polley, Steven N Hart, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Association of Gene Variant Type and Location with Breast Cancer Risk in the General PopulationMwangala P Akamandisa, Nicholas J Boddicker, Siddhartha Yadav, et al.
Pageof 37

Showing results (271-280 of 361) with videos related to

Sort By:
Pageof 37
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 8, 2024
Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma In Situ of the BreastHuaizhi Huang, Ronan E Couch, Rachid Karam, et al.
JAMA Oncology|October 9, 2025
Pathogenic Variants, Family History, and Cumulative Risk of Breast Cancer in US WomenKatie M O'Brien, Alexander P Keil, Jack A Taylor, et al.
Cancer Research|May 30, 2023
Functional and Clinical Characterization of Variants of Uncertain Significance Identifies a Hotspot for Inactivating Missense Variants in RAD51CChunling Hu, Anil Belur Nagaraj, Hermela Shimelis, et al.
Plos Genetics|December 27, 2018
BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2Melissa S Cline, Rachel G Liao, Michael T Parsons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2024
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in g<i>BRCA1/2</i> Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast CancerPatricia A Ganz, Hanna Bandos, Tanja Španić, et al.
Human Molecular Genetics|April 27, 2010
Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriersXianshu Wang, V Shane Pankratz, Zachary Fredericksen, et al.
The New England Journal of Medicine|August 8, 2014
Breast-cancer risk in families with mutations in PALB2Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, et al.
Human Mutation|May 22, 2019
BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestryTara M Friebel, Irene L Andrulis, Judith Balmaña, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2021
Risk of Breast Cancer Among Carriers of Pathogenic Variants in Breast Cancer Predisposition Genes Varies by Polygenic Risk ScoreChi Gao, Eric C Polley, Steven N Hart, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Association of Gene Variant Type and Location with Breast Cancer Risk in the General PopulationMwangala P Akamandisa, Nicholas J Boddicker, Siddhartha Yadav, et al.
Pageof 37